Cargando…

Antiviral prophylaxis inhibits cytomegalovirus reactivation in critical illness

Detalles Bibliográficos
Autores principales:	Cowley, NJ, Owen, A, Millar, J, Shiels, SC, Woolley, RL, Ives, NJ, Osman, H, Moss, P, Bion, JF
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470438/ http://dx.doi.org/10.1186/cc14195

Ejemplares similares

Cytomegalovirus Reactivation in Critically-ill COVID-19 Patients
por: Talan, Leyla, et al.
Publicado: (2022)

Cytomegalovirus reactivation and associated outcome of critically ill patients with severe sepsis
por: Heininger, Alexandra, et al.
Publicado: (2011)

Cytomegalovirus reactivation in a critically ill patient: a case report
por: Demirkol, Demet, et al.
Publicado: (2018)

Cytomegalovirus reactivation in critically ill burn patients: it’s time to worry about it!
por: Bordes, Julien, et al.
Publicado: (2014)

The Association Between Cytomegalovirus Infection and Cardiac Allograft Vasculopathy in the Era of Antiviral Valganciclovir Prophylaxis
por: Klimczak-Tomaniak, Dominika, et al.
Publicado: (2019)

Cytomegalovirus mismatch after heart transplantation: Impact of antiviral prophylaxis and intravenous hyperimmune globulin
por: Immohr, Moritz B., et al.
Publicado: (2021)

Letermovir for cytomegalovirus prophylaxis
Publicado: (2019)

Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality
por: Gatto, Ilenia, et al.
Publicado: (2022)

Antifungal prophylaxis in critically ill patients
por: Silvestri, Luciano, et al.
Publicado: (2008)

Does Cytomegalovirus Develop Resistance following Antiviral Prophylaxis and Treatment in Renal Transplant Patients in Kuwait?
por: Madi, Nada, et al.
Publicado: (2011)

Cytomegalovirus reactivation in critically-ill Coronavirus Disease 2019 patients: A case series of 11 patients
por: Kim, Myeongji, et al.
Publicado: (2022)

Cytomegalovirus infection in critically ill patients with COVID-19
por: Niitsu, Takayuki, et al.
Publicado: (2021)

Antiviral prophylaxis or preemptive therapy for cytomegalovirus after liver transplantation?: A systematic review and meta-analysis
por: Yadav, Dipesh Kumar, et al.
Publicado: (2022)

Thrombo-prophylaxis in acutely ill medical and critically ill patients
por: Saigal, Saurabh, et al.
Publicado: (2014)

Prophylaxis and treatment of venous thromboembolism in the critically ill
por: Adriance, Sarah M, et al.
Publicado: (2013)

Antiviral agents in the critically ill child
por: Munoz, Flor M.
Publicado: (2000)

Relationship between plasma NGAL and serum creatinine is influenced by leucocytosis and neutrophilia in the critically ill
por: Glassford, NJ, et al.
Publicado: (2012)

The Impact of Direct-Acting Antiviral Agents on Cytomegalovirus Reactivation in Chronic Hepatitis C Infection
por: Dawood, Reham M, et al.
Publicado: (2022)

Cytomegalovirus viraemia and mortality in renal transplant recipients in the era of antiviral prophylaxis. Lessons from the western Australian experience
por: Selvey, Linda A., et al.
Publicado: (2017)

Association Between Cytomegalovirus Reactivation and Clinical Outcomes in Immunocompetent Critically Ill Patients: A Systematic Review and Meta-Analysis
por: Lachance, Philippe, et al.
Publicado: (2017)

Impact of cytomegalovirus reactivation on clinical outcomes in immunocompetent critically ill patients: protocol for a systematic review and meta-analysis
por: Lachance, Philippe, et al.
Publicado: (2016)

Cytomegalovirus infection in critically ill patients: a systematic review
por: Osawa, Ryosuke, et al.
Publicado: (2009)

Cytomegalovirus infection in immunocompetent critically ill adults: literature review
por: Al-Omari, Awad, et al.
Publicado: (2016)

The Potential Harm of Cytomegalovirus Infection in Immunocompetent Critically Ill Children
por: Alyazidi, Raidan, et al.
Publicado: (2018)

Antiviral Immunity and Prophylaxis
Publicado: (2011)

Stress ulcer prophylaxis in critically ill poisoned patients
por: Mehrpour, Omid, et al.
Publicado: (2012)

Efficacy of a palliative care program in critically ill patients
por: Ribeiro, SCF, et al.
Publicado: (2011)

454 Cytomegalovirus (CMV) Disease after Lung Transplantation (LT) is associated with increased mortality despite Extended Antiviral Prophylaxis
por: Beam, Elena, et al.
Publicado: (2014)

Antiviral drugs–: history and obstacles
por: Korsman, Stephen N.J., et al.
Publicado: (2012)

High incidence of Epstein–Barr virus, cytomegalovirus, and human-herpes virus-6 reactivations in critically ill patients with COVID-19
por: Simonnet, A., et al.
Publicado: (2021)

Association between Pulmonary Aspergillosis and Cytomegalovirus Reactivation in Critically Ill COVID-19 Patients: A Prospective Observational Cohort Study
por: Caciagli, Valeria, et al.
Publicado: (2023)

Reactivation of latent Histoplasma and disseminated cytomegalovirus in a returning traveller with ulcerative colitis
por: Lucey, Olivia, et al.
Publicado: (2018)

Immune Prophylaxis and Therapy for Human Cytomegalovirus Infection
por: Struble, Evi B., et al.
Publicado: (2021)

Adoptive Immunotherapy for Prophylaxis and Treatment of Cytomegalovirus Infection
por: Ouellette, Christopher P.
Publicado: (2022)

Fatal cytomegalovirus pneumonia in a critically ill patient with COVID‐19
por: Amiya, Saori, et al.
Publicado: (2021)

Erythropoietin mimics the acute phase response in critical illness
por: Elliot, John Michael, et al.
Publicado: (2003)

Geochemical Multisurface Modeling of Reactive Zinc Speciation in Compost as Influenced by Extraction Conditions
por: Klinkert, Susan, et al.
Publicado: (2020)

Association between Antiviral Prophylaxis and Cytomegalovirus and Epstein–Barr Virus DNAemia in Pediatric Recipients of Allogeneic Hematopoietic Stem Cell Transplant
por: Diop, Ndeye Soukeyna, et al.
Publicado: (2021)

Cytomegalovirus Disease as a Risk Factor for Invasive Fungal Infections in Liver Transplant Recipients under Targeted Antiviral and Antimycotic Prophylaxis
por: Breitkopf, Robert, et al.
Publicado: (2023)

A critical analysis of the noninferiority design of the TALENT trial
por: Saha, S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1c15l34q2jho0l3g91blvmpbmg